|
1
|
Li D, Wang B, Hu Q, Shen Y, Xu D, Wang T
and Wen F: Diagnostic accuracy of MOC-31 for malignant effusions: A
meta-analysis. Tumour Biol. 35:6003–6009. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang B, Li D, Ou X, Yi Q and Feng Y:
Diagnostic accuracy of Ber-EP4 for metastatic adenocarcinoma in
serous effusions: A meta-analysis. PLoS One. 17:e1077412014.
View Article : Google Scholar
|
|
3
|
Schnell U, Cirulli V and Giepmans BN:
EpCAM: Structure and function in health and disease. Biochim
Biophys Acta. 1828:1989–2001. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Litvinov SV, Velders MP, Bakker HA,
Fleuren GJ and Warnaar SO: Ep-CAM: A human epithelial antigen is a
homophilic cell-cell adhesion molecule. J Cell Biol. 125:437–446.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Winter MJ, Nagelkerken B, Mertens AE,
Rees-Bakker HA, Briaire-de Bruijn IH and Litvinov SV: Expression of
EpCAM shifts the state of cadherin-mediated adhesions from strong
to weak. Exp Cell Res. 285:50–58. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maetzel D, Denzel S, Mack B, Canis M, Went
P, Benk M, Kieu C, Papior P, Baeuerle PA, Münz M and Gires O:
Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell
Biol. 11:162–171. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chaves-Pérez A, Mack B, Maetzel D,
Kremling H, Eggert C, Harréus U and Gires O: EpCAM regulates cell
cycle progression via control of cyclin D1 expression. Oncogene.
32:641–650. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Du W, Ji H, Cao S, Wang L, Bai F, Liu J
and Fan D: EpCAM: A potential antimetastatic target for gastric
cancer. Dig Dis Sci. 55:2165–2171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Baeuerle PA and Gires O: EpCAM (CD326)
finding its role in cancer. Br J Cancer. 96:417–423. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Strand J, Hamilton AE, Beavers LS, Gamboa
GC, Apelgren LD, Taber LD, Sportsman JR, Bumol TF, Sharp JD and
Gadski RA: Molecular cloning and characterization of a human
adenocarcinoma/epithelial cell surface antigen complementary DNA.
Cancer Res. 49:314–317. 1989.PubMed/NCBI
|
|
11
|
Winter MJ, Nagtegaal ID, van Krieken JH
and Litvinov SV: The epithelial cell adhesion molecule (Ep-CAM) as
a morphoregulatory molecule is a tool in surgical pathology. Am J
Pathol. 163:2139–2148. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schnell U, Kuipers J and Giepmans BN:
EpCAM proteolysis: New fragments with distinct functions? Biosci
Rep. 33:e000302013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gastl G, Spizzo G, Obrist P, Dünser M and
Mikuz G: Ep-CAM overexpression in breast cancer as a predictor of
survival. Lancet. 356:1981–1982. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Carneiro FP, Muniz-Junqueira MI,
Pittella-Silva F, Carneiro MV, Takano GHS, Vianna LMS, De Andrade
LB, De Castro TMML, Peres I, Dos Santos Borges TK, et al: A panel
of markers for identification of malignant and non-malignant cells
in culture from effusions. Oncol Rep. 38:3538–3544. 2017.PubMed/NCBI
|
|
15
|
Fetsch PA, Simsir A, Brosky K and Abati A:
Comparison of three commonly used cytologic preparations in
effusion immunocytochemistry. Diagn Cytopathol. 26:61–66. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nigro K, Tynski Z, Wasman J, Abdul-Karim F
and Wang N: Comparison of cell block preparation methods for
nongynecologic ThinPrep specimens. Diagn Cytopathol. 35:640–643.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oda T, Ogata S, Kawaguchi S, Minabe S,
Dokyu M, Takahashi H, Kumazawa F, Shimazaki H, Takano M, Hase K, et
al: Immunocytochemical utility of claudin-4 versus those of Ber-EP4
and MOC-31 in effusion cytology. Diagn Cytopathol. 44:499–504.
2016. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jo VY, Cibas ES and Pinkus GS: Claudin-4
immunohistochemistry is highly effective in distinguishing
adenocarcinoma from malignant mesothelioma in effusion cytology.
Cancer Cytopathol. 122:299–306. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Balzar M, Briaire-de Bruijn IH,
Rees-Bakker HA, Prins FA, Helfrich W, de Leij L, Riethmuller G,
Alberti S, Warnaar SO, Fleuren GJ and Litvinov SV: Epidermal growth
factor-like repeats mediate lateral and reciprocal interactions of
Ep-CAM molecules in homophilic adhesions. Mol Cell Biol.
21:2570–2580. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fong D, Seeber A, Terracciano L, Kasal A,
Mazzoleni G, Lehne F, Gastl G and Spizzo G: Expression of EpCAM(MF)
and EpCAM(MT) variants in human carcinomas. J Clin Pathol.
67:408–414. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Spizzo G, Fong D, Wurm M, Ensinger C,
Obrist P, Hofer C, Mazzoleni G, Gastl G and Went P: EpCAM
expression in primary tumour tissues and metastases: An
immunohistochemical analysis. J Clin Pathol. 64:415–420. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Went PT, Lugli A, Meier S, Bundi M,
Mirlacher M, Sauter G and Dirnhofer S: Frequent EpCam protein
expression in human carcinomas. Hum Pathol. 35:122–128. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pu RT, Pang Y and Michael CW: Utility of
WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6)
immunostains in differentiating adenocarcinoma, squamous cell
carcinoma, and malignant mesothelioma in effusions. Diagn
Cytopathol. 36:20–25. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chantima W, Thepthai C, Cheunsuchon P and
Dharakul T: EpCAM expression in squamous cell carcinoma of the
uterine cervix detected by monoclonal antibody to the
membrane-proximal part of EpCAM. BMC Cancer. 17:8112017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gosens MJ, van Kempen LC, van de Velde CJ,
van Krieken JH and Nagtegaal ID: Loss of membranous Ep-CAM in
budding colorectal carcinoma cells. Mod Pathol. 20:221–232. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Herreros-Pomares A, Aguilar-Gallardo C,
Calabuig-Fariñas S, Sirera R, Jantus-Lewintre E and Camps C: EpCAM
duality becomes this molecule in a new Dr. Jekyll and Mr. Hyde
tale. Crit Rev Oncol Hematol. 126:52–63. 2018. View Article : Google Scholar : PubMed/NCBI
|
